Faecal microbial metabolites of proteolytic and saccharolytic fermentation in relation to degree of insulin resistance in adult individuals
- 15 June 2021
- journal article
- research article
- Published by Wageningen Academic Publishers in Beneficial Microbes
- Vol. 12 (3), 259-266
- https://doi.org/10.3920/bm2020.0179
Abstract
The gut microbiota may affect host metabolic health through microbial metabolites. The balance between the production of microbial metabolites by saccharolytic and proteolytic fermentation may be an important determinant of metabolic health. Amongst the best-studied saccharolytic microbial metabolites are the short-chain fatty acids acetate, propionate and butyrate. However, human data on the role of other microbial fermentation by-products in metabolic health are greatly lacking. Therefore, we compared in a cross-sectional study the faecal microbial metabolites (caproate, lactate, valerate, succinate, and the branched-chain fatty acids (BCFA) (isobutyrate, isovalerate)) between insulin sensitive (homeostatic model assessment of insulin resistance (HOMA-IR), HOMA-IR1.85, IR) individuals. Additionally, we assessed the relationships between faecal metabolites and markers of metabolic health including fasting glucose, insulin, free fatty acids, insulin resistance (HOMA-IR) and fasting substrate oxidation in 86 individuals with a wide range of body mass index. Faecal metabolite concentrations did not significantly differ between IS and IR. Furthermore, there were no associations between microbial metabolites and metabolic health markers, except for a slight positive association of isovalerate with carbohydrate oxidation (E%, std β 0.194, P=0.011) and fat oxidation (E%, std β -0.075, P=0.047), also after adjustment for age, sex and BMI. In summary, faecal caproate, lactate, valerate, succinate, and BCFA (isobutyrate, isovalerate) were not different between IR and IS individuals, nor was there any association between these faecal metabolites and parameters of metabolic health. Further human intervention studies are warranted to investigate the role of these microbially-derived fermentation products and their kinetics in metabolic health and insulin sensitivity.Keywords
This publication has 46 references indexed in Scilit:
- Circulating microbiota-derived metabolites: a “liquid biopsy?International Journal of Obesity, 2019
- Gut microbial metabolites in obesity, NAFLD and T2DMNature Reviews Endocrinology, 2019
- High-protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study groupClinical Nutrition, 2018
- Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjectsClinical and Translational Gastroenterology, 2018
- The Gut Microbiome Profile in Obesity: A Systematic ReviewInternational Journal of Endocrinology, 2018
- Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistanceScientific Reports, 2018
- Short-chain fatty acids in control of body weight and insulin sensitivityNature Reviews Endocrinology, 2015
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolismJournal of Lipid Research, 2013
- Enterotypes of the human gut microbiomeNature, 2011
- New methods for calculating metabolic rate with special reference to protein metabolismJournal Of Physiology-London, 1949